• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • Exchange Traded Funds
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Drugs - Generic

       Total Market Capitalization of All Firms 117180 mm             
       Average Market Capitalization 23436 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 0.76       
       Standard Deviation of MM Ratio 0       
       Average Beta 1.31       
       Average EV To Revenue 3.77       
       Average Price To Free Cash Flow 25.52       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCF% GrowthBetaAs Of
ANIPANI Pharmaceuticals Inc0.96324.276.3142.43Jun 18
MYLMylan N.V.0.920,7683.011.701.38Jun 18
RDYDr Reddy Laboratories Ltd0.96,0953.118.670.14Jun 18
AGNAllergan PLC0.664,3585.712.451.17Jun 18
TEVATeva Pharmaceutical Industries0.625,3273.08.6-131.42Jun 18
Standard Value | About us | Contact us     Copyright © 2003-2018 Rational Investing LLC ® | All Rights Reserved